Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

7 evidences · page 1 / 1

2,3 odds_ratioThe combined effect of diabetes mellitus on tuberculosis risk was an odds ratio of 2.3 with a 95% confidence interval of [2.0–2.7].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

2 odds_ratioThe odds ratio for tuberculosis risk in cohort studies with diabetes mellitus was 2.0 with a 95% confidence interval of [1.5–2.4].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

2,5 odds_ratioThe odds ratio for tuberculosis risk in cross-sectional studies with diabetes mellitus was 2.5 with a 95% confidence interval of [1.8–3.5].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

2,4 odds_ratioThe odds ratio for tuberculosis risk in case control studies with diabetes mellitus was 2.4 with a 95% confidence interval of [2.0–2.9].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

503 760 casesThe systematic review included 503,760 cases (diabetes mellitus or tuberculosis patients).

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

0,4 odds_ratioThe slow acetylation variant NAT2*5 was associated with a decreased risk of drug-induced hepatotoxicity (OR: 0.4; 95%CI: 0.17–0.96; p = 0.038) among patients treated for tuberculosis in Cameroon.

Camerountuberculoseobservé 2018-2019publié 2024BMC infectious diseaseseurope_pmcdocument de 4 observations

4,2 odds_ratioThe NAT2*6 variant was associated with an increased risk of drug-induced hepatotoxicity (OR: 4.2; 95%CI: 1.1–15.2; p = 0.017) among patients treated for tuberculosis in Cameroon.

Camerountuberculoseobservé 2018-2019publié 2024BMC infectious diseaseseurope_pmcdocument de 4 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.